Vivos Therapeutics Inc
(NAS:VVOS)
$
4.37
0.0161 (0.37%)
Market Cap: 25.74 Mil
Enterprise Value: 20.97 Mil
PE Ratio: 0
PB Ratio: 2.71
GF Score: 58/100 Vivos Therapeutics Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Dec 09, 2021 / 06:55PM GMT
Release Date Price:
$71.5
(+2.14%)
Brent Slava
Benzinga - Moderator
And I want to bring on Vivos Therapeutics' Co-Founder and CEO, Kirk Huntsman. Kirk, nice to see you here.
Kirk Huntsman
Vivos Therapeutics, Inc. - Chairman & CEO
Hi, Brent. Nice to be here. Thanks for having us.
Brent Slava
Benzinga - Moderator
Yeah. And it looks like your CFO, Brad, is also here. Nice to meet you, Brad. Nice to see you.
Brad Amman
Vivos Therapeutics, Inc. - CFO
Yeah, good to see you, Brent.
Brent Slava
Benzinga - Moderator
Cool. Well, I will let you guys have at it. I see some slides backstage and who -- whichever one of you guys is controlling that just make it full screen if you can, and we should be good to go.
Kirk Huntsman;Brent Slava
Vivos Therapeutics, Inc. - Chairman & CEO;Benzinga - Moderator
So I thought I did. Let me make sure. How's that? Does that look full screen now?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot